Moleculin Biotech, Inc. (MBRX) Financials

MBRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 39.5 million 4.4 million
2023-06-30 47.1 million 6.8 million
2023-03-31 51.1 million 5.4 million
2022-12-31 57.4 million 5.2 million

MBRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -7.6 million 493000
2023-06-30 -5.1 million 513000
2023-03-31 -6.0 million 499000
2022-12-31 -7.3 million 535000

MBRX Net Income

No data available :(

MBRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 24.6 million - 496000
2023-06-30 32.2 million - 291000
2023-03-31 37.3 million - 308000
2022-12-31 43.1 million - 451000

MBRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 29.8 million
2023-06-30 29.7 million
2023-03-31 28.7 million
2022-12-31 28.6 million

MBRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 28000 3.3 million 2.6 million -
2023-06-30 15000 3.9 million 2.5 million -
2023-03-31 15000 5.7 million 2.7 million -
2022-12-31 67000 4.2 million 2.8 million -

MBRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 32000
2023-06-30 - 31000
2023-03-31 - 140000
2022-12-31 - 28000

MBRX

Price: $5.02

52 week price:
0.34
6.24

Earnings Per Share: -15.15 USD

P/E Ratio: -0.56

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 14187

Ebitda: -2.9 million

Market Capitalization: 11.8 million

Links: